SRSF2 and chronic myelomonocytic leukemia: Previous studies have shown that CMML clonal driver mutations can be detected in over 90% of cases, with the combination of TET2 (particularly biallelic mutations) and SRSF2 being highly specific for a myelomonocytic phenotype [19].